Eyebright Medical Technology’s Intraocular Lenses Earn Fast-Track Status in China

Beijing-based Eyebright Medical Technology Co., Ltd (SHE: 688050) has announced that its “intraocular lenses with crystalline eyes” have been granted fast-track status as an innovative medical device in China. This designation underscores the potential impact of the company’s technology on the field of ophthalmology.

Refractive Intraocular Lenses for Myopia Correction
The intraocular lenses with crystalline eyes are a type of refractive intraocular lens designed to serve as refractive elements once implanted in the eye, reducing or correcting myopia. This innovative approach offers a significant advancement over traditional methods of vision correction, such as wearing frame lenses or contact lenses.

Safety and Efficacy of the Device
The implantation of intraocular lenses with crystalline eyes has been proven to be a safe and effective method for correcting myopia. This procedure not only corrects vision but also alleviates the daily challenges associated with wearing frame lenses and contact lenses, offering a more convenient and permanent solution for patients.-Fineline Info & Tech

Fineline Info & Tech